Company Filing History:
Years Active: 2010
Title: Armin Weidmann: Innovator in Antibody Research
Introduction
Armin Weidmann is a notable inventor based in Dießen am Ammersee, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific fibronectin isoforms. His work has implications for both diagnostic and therapeutic applications.
Latest Patents
Weidmann holds a patent for the invention titled "Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies." This invention focuses on recombinant polypeptides, specifically antibodies or antibody fragments that bind to Ed-B isoforms of fibronectin and can inhibit their function. The patent also discusses the diagnostic and pharmaceutical applications of these polypeptides, showcasing their potential in medical science.
Career Highlights
Armin Weidmann is associated with Morphosys AG, a company known for its innovative approaches in the field of biotechnology. His work at Morphosys AG has allowed him to contribute to cutting-edge research and development in antibody technology.
Collaborations
Throughout his career, Weidmann has collaborated with esteemed colleagues such as Andreas Menrad and Josef Prassler. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Armin Weidmann's contributions to antibody research exemplify the importance of innovation in biotechnology. His patent on function-blocking anti-ED-B-fibronectin antibodies highlights the potential for advancements in diagnostics and therapeutics.